Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377948 · ClinicalTrials.gov registry record · Phase 1
Reducing Aggression in Children and Adolescent on an Inpatient Unit
A Phase 1 study of Aggression and Anger, sponsored by Gonzalez-Heydrich, Joseph, M.D..
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01377948: Completed Phase 1 study of Aggression and Anger, sponsored by Gonzalez-Heydrich, Joseph, M.D..
NCT01377948 is a Phase 1 study of Aggression and Anger that has completed, run by Gonzalez-Heydrich, Joseph, M.D.. The registered enrollment target is 20 participants, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01377948, a Phase 1 study of Aggression and Anger, has completed, sponsored by Gonzalez-Heydrich, Joseph, M.D..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether Anger Control Therapy (ACT) with Regulate and Gain Emotional-Control (RAGE-Control) is a feasible behavioral therapy to provide on a pediatric inpatient psychiatric unit.
Conditions Studied
Interventions
- BEHAVIORAL ACT with RAGE-Control
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
What the finished NCT01377948 record still lists
NCT01377948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Aggression appearing as the primary indexed condition, and to 1 intervention - of which ACT with RAGE-Control is the first listed.
NCT01377948 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01377948 about?
NCT01377948 is a clinical study titled "Reducing Aggression in Children and Adolescent on an Inpatient Unit". The purpose of this study is to determine whether Anger Control Therapy (ACT) with Regulate and Gain Emotional-Control (RAGE-Control) is a feasible behavioral therapy to provide on a pediatric inpatient psychiatric unit.
What is the current status of trial NCT01377948?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-06. Estimated completion is 2011-10.
What conditions does trial NCT01377948 study?
This clinical trial studies the following conditions: Aggression, Anger.
What interventions are being tested in trial NCT01377948?
The interventions under investigation include: ACT with RAGE-Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01377948?
This trial is sponsored by Gonzalez-Heydrich, Joseph, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01377948 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01377948's enrollment target sits among peer trials
20 21st of 21 higher than 1 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
RECRUITING · Phase 2
-
Clinical Trial on Agitation in Alzheimer's Dementia
RECRUITING · Phase 2
-
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia